Retractable Technologies (RVP)
XASE:RVP
Want to see RVP full AI Analyst Report?
Top Page
Retractable Technologies
(NYSE MKT:RVP)
Select Model
Select Model
Rating:46Neutral
Price Target:
$0.70
▼(-4.25% Downside)
Action:Reiterated
Date:05/16/26
The score is weighed down most by deteriorating operating performance and continued cash burn alongside multi-year losses. Technicals also indicate a weak trend with the stock trading below major moving averages. Valuation is not supportive given negative earnings and no provided dividend yield.
Positive Factors
Low leverage and strong balance-sheet flexibility
Extremely low debt relative to equity gives the company durable financial flexibility, lowering solvency risk and preserving options for restructuring, working-capital support, or targeted investment over the next 2–6 months without immediate refinancing pressure.
Negative Factors
Declining revenue and negative margins
Substantially lower top line and negative gross margins indicate structural pricing pressure or cost misalignment. Persistent negative margins erode core profitability, limit reinvestment capacity, and threaten long-term viability unless cost base or pricing recovers.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage and strong balance-sheet flexibility
Extremely low debt relative to equity gives the company durable financial flexibility, lowering solvency risk and preserving options for restructuring, working-capital support, or targeted investment over the next 2–6 months without immediate refinancing pressure.
Read all positive factors
Retractable Technologies (RVP) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$21.35M
Dividend YieldN/A
Average Volume (3M)153.51K
Price to Earnings (P/E)―
Beta (1Y)0.49
Revenue Growth10.08%
EPS Growth71.71%
CountryUS
Employees221
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)-0.21
Shares Outstanding29,937,159
10 Day Avg. Volume341,920
30 Day Avg. Volume153,511
Financial Highlights & Ratios
PEG Ratio-0.25
Price to Book (P/B)0.31
Price to Sales (P/S)0.60
P/FCF Ratio-3.04
Enterprise Value/Market Cap0.91
Enterprise Value/Revenue0.52
Enterprise Value/Gross Profit264.93
Enterprise Value/Ebitda-52.05
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Retractable Technologies Business Overview & Revenue Model
Company Description
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers Vanis...
How the Company Makes Money
Retractable Technologies makes money primarily by selling its safety medical devices (especially retractable safety syringes and related injection/safety needle products) to healthcare customers through a mix of direct sales and distribution chann...
Retractable Technologies Financial Statement Overview
Summary
Income Statement
22
Negative
Balance Sheet
72
Positive
Cash Flow
28
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.15M | 38.27M | 33.05M | 43.60M | 94.82M | 188.38M |
| Gross Profit | 73.59K | 47.05K | -1.03M | 9.11M | 28.25M | 95.35M |
| EBITDA | -374.53K | -12.45M | 4.17M | -1.24M | 9.94M | 76.44M |
| Net Income | -6.29M | -12.57M | -11.89M | -7.01M | 5.08M | 56.06M |
Balance Sheet | ||||||
| Total Assets | 137.60M | 142.63M | 160.72M | 179.67M | 210.74M | 213.15M |
| Cash, Cash Equivalents and Short-Term Investments | 35.62M | 36.97M | 44.56M | 47.29M | 49.38M | 42.43M |
| Total Debt | 916.05K | 895.64K | 1.23M | 1.54M | 2.92M | 4.24M |
| Total Liabilities | 67.50M | 68.26M | 73.55M | 80.38M | 104.21M | 113.98M |
| Stockholders Equity | 70.09M | 74.38M | 87.17M | 99.29M | 106.54M | 99.17M |
Cash Flow | ||||||
| Free Cash Flow | -7.41M | -7.60M | -13.00M | 1.91M | -61.95K | -25.57M |
| Operating Cash Flow | -6.96M | -7.06M | -11.56M | 2.77M | 16.77M | 32.79M |
| Investing Cash Flow | 6.91M | 5.98M | 3.66M | -10.76M | -31.20M | -63.04M |
| Financing Cash Flow | -574.62K | -567.32K | -535.43K | 941.64K | 4.99M | 41.84M |
Retractable Technologies Technical Analysis
Positive
0.73
Price Trends
0.68
Positive
0.69
Positive
0.77
Negative
Market Momentum
<0.01
Negative
56.54
Neutral
39.76
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RVP, the sentiment is Positive. The current price of 0.73 is above the 20-day moving average (MA) of 0.67, above the 50-day MA of 0.68, and below the 200-day MA of 0.77, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 56.54 is Neutral, neither overbought nor oversold. The STOCH value of 39.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RVP.
Retractable Technologies Risk Analysis
Retractable Technologies disclosed 18 risk factors in its most recent earnings report. Retractable Technologies reported the most risks in the "Macro & Political" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Retractable Technologies Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
55 Neutral | $212.33M | 81.48 | -246.44% | ― | 17.41% | -189.91% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | $248.54M | -2.34 | -21.50% | ― | -30.08% | -143.79% | |
49 Neutral | $187.65M | -7.76 | -153.21% | ― | 13.40% | 20.97% | |
49 Neutral | $33.73M | -7.04 | -166.28% | ― | 3.37% | 15.78% | |
46 Neutral | $21.35M | -1.17 | -8.13% | ― | 10.08% | 71.71% |
* Healthcare Sector Average
RVP
Retractable Technologies
0.71
0.06
9.86%
OSUR
Orasure Technologies
3.61
1.09
43.25%
STXS
Stereotaxis
1.92
-0.15
-7.25%
MLSS
Milestone Scientific
0.38
-0.61
-61.51%
SMTI
Sanara MedTech
23.17
-7.61
-24.72%
STSS
Sharps Technology, Inc.
1.81
-2.02
-52.74%
Retractable Technologies Corporate Events
Financial Disclosures
Retractable Technologies Releases First-Quarter 2026 Financial Results
Neutral
May 15, 2026
Retractable Technologies reported that on May 15, 2026, it released its financial results for the quarter ended March 31, 2026. The announcement formalizes the company’s disclosure of first-quarter performance, providing stakeholders with up...
Executive/Board ChangesShareholder Meetings
Retractable Technologies Shareholders Reelect Class 2 Directors
Positive
May 13, 2026
Retractable Technologies, Inc. held its Annual Meeting of Shareholders as a virtual event on May 8, 2026, where shareholders voted on the election of Class 2 directors. All three Board-nominated Class 2 directors, Thomas J. Shaw, Walter O. Bigby, ...
Business Operations and Strategy
Retractable Technologies Announces Workforce Reduction and Restructuring Plan
Negative
Apr 10, 2026
On April 9, 2026, Retractable Technologies announced it was reducing its workforce, signaling a significant change in the company’s operational structure. The job cuts suggest management is undertaking cost-cutting or restructuring measures ...
Business Operations and StrategyDividendsFinancial Disclosures
Retractable Technologies Declares Preferred Dividend Amid Tariff Pressures
Negative
Mar 27, 2026
Retractable Technologies, Inc., a maker of safety syringes, needles, and related medical devices, reported that revenues for 2025 rose 15.8% to approximately $38.3 million, driven by higher domestic VanishPoint and EasyPoint needle sales and a 64....
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.